- 专利标题： HETEROCYCLIC COMPOUND AND USE THEREOF
-
申请号： US18592897申请日： 2024-03-01
-
公开(公告)号： US20240360156A1公开(公告)日： 2024-10-31
- 发明人: Masakuni KORI , Toshihiro IMAEDA , Shinji NAKAMURA , Masashi TOYOFUKU , Eiji HONDA , Yasutomi ASANO , Osamu UJIKAWA , Michiyo MOCHIZUKI
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka-shi
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka-shi
- 优先权： JP 10179577 2010.08.10
- 主分类号： C07D513/04
- IPC分类号： C07D513/04
摘要：
Provided is a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
信息查询
